AMNEAL PHARMACEUTICALS, INC. Other Accrued Liabilities, Current
AMNEAL PHARMACEUTICALS, INC. (AMRX) had Other Accrued Liabilities, Current of $60.28 million as of 2025-09-30, per its 10-Q filed 2025-11-06.
Financial Statements › Notes › Accrued Liabilities, Current
us-gaap:OtherAccruedLiabilitiesCurrent · last filed 2025-11-06
- 2025-09-30: Other Accrued Liabilities, Current $60.28M.
- 2025-06-30: Other Accrued Liabilities, Current $77.72M.
- 2025-03-31: Other Accrued Liabilities, Current $60.07M.
- 2024-12-31: Other Accrued Liabilities, Current $56.57M.
| Period end | Other Accrued Liabilities, Current | Other Accrued Liabilities, Current as first filed |
|---|---|---|
| 2025-09-30 | $60.28M 10-Q · filed 2025-11-06 | |
| 2025-06-30 | $77.72M 10-Q · filed 2025-08-07 | |
| 2025-03-31 | $60.07M 10-Q · filed 2025-05-07 | |
| 2024-12-31 | $56.57M 10-Q · filed 2025-11-06 | |
| 2024-09-30 | $54.13M 10-Q · filed 2024-11-12 | |
| 2024-06-30 | $55.58M 10-Q · filed 2024-08-09 | |
| 2024-03-31 | $59.97M 10-Q · filed 2024-05-08 | |
| 2023-12-31 | $48.22M 10-Q · filed 2024-11-12 | |
| 2023-09-30 | $55.45M 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $44.47M 10-Q · filed 2023-08-08 | |
| 2023-03-31 | $44.45M 10-Q · filed 2023-05-09 | |
| 2022-12-31 | $46.17M 10-Q · filed 2023-11-09 | $45.81M 10-K · filed 2023-03-03 |
| 2021-12-31 | $40.88M 10-K · filed 2023-03-03 | |
| 2020-12-31 | $34.44M 10-K · filed 2022-03-01 | $46.93M 10-K · filed 2021-03-01 |
| 2019-12-31 | $35.90M 10-K · filed 2021-03-01 | |
| 2018-12-31 | $36.19M 10-K · filed 2020-03-02 | $37.35M 10-K · filed 2019-03-01 |
| 2018-09-30 | $30.50M 10-Q · filed 2018-11-07 | |
| 2018-06-30 | $35.18M 10-Q · filed 2018-08-09 | |
| 2017-12-31 | $23.82M 10-K · filed 2019-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |